Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
(JNJ) Trading Advice | news.google.com • |
Johnson & Johnson Stock: Buy, Sell, or Hold? | fool.com • |
Johnson & Johnson Stock: Buy, Sell, or Hold? | news.google.com • |
Generational Wealth Builders: 3 Stocks to Own for Decades of Gains | investorplace.com • |
Brendel Financial Advisors LLC Makes New $918000 Investment in Johnson & Johnson (NYSE:JNJ) | news.google.com • |
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-16 | 2024-03 | 2.64 | 2.71 | 0.07 | 2.65% |
2024-01-23 | 2023-12 | 2.27 | 2.29 | 0.02 | 0.88% |
2023-10-17 | 2023-09 | 2.52 | 2.66 | 0.14 | 5.56% |
2023-07-20 | 2023-06 | 2.61 | 2.8 | 0.19 | 7.28% |
2023-04-18 | 2023-03 | 2.51 | 2.68 | 0.17 | 6.77% |
2023-01-24 | 2022-12 | 2.22 | 2.35 | 0.13 | 5.86% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-17 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-17 | Raymond James | Upgrade | Outperform | Outperform |
2023-10-17 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-11 | Barclays | Upgrade | Equal-Weight | Equal-Weight |
2023-10-10 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-10 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-12 | BROADHURST VANESSA | Officer | 15.04K | Sale |
2024-02-12 | DECKER ROBERT J | Officer | 19.70K | Conversion of Exercise of derivative security |
2024-02-12 | DUATO JOAQUIN BOIX | Chief Executive Officer | 364.19K | Conversion of Exercise of derivative security |
2024-02-12 | FASOLO PETER M | Officer | 112.08K | Conversion of Exercise of derivative security |
2024-02-12 | FORMINARD ELIZABETH | General Counsel | 8.34K | Conversion of Exercise of derivative security |
2024-02-12 | HAIT WILLIAM | Officer | 38.65K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 247.48M | 40.96B | 9.52% |
2023-06-29 | Blackrock Inc. | 199.34M | 33.00B | 7.67% |
2023-06-29 | State Street Corporation | 141.83M | 23.48B | 5.46% |
2023-06-29 | Geode Capital Management, LLC | 49.70M | 8.23B | 1.91% |
2023-06-29 | Morgan Stanley | 41.67M | 6.90B | 1.60% |
2023-06-29 | JP Morgan Chase & Company | 31.78M | 5.26B | 1.22% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 81.05M | 13.42B | 3.12% |
2023-06-29 | Vanguard 500 Index Fund | 61.87M | 10.24B | 2.38% |
2023-05-30 | Fidelity 500 Index Fund | 29.26M | 4.54B | 1.13% |
2023-08-30 | SPDR S&P 500 ETF Trust | 26.52M | 4.29B | 1.02% |
2023-06-29 | Vanguard Index-Value Index Fund | 22.57M | 3.74B | 0.87% |
2023-08-30 | iShares Core S&P 500 ETF | 22.52M | 3.64B | 0.87% |
Dividend | Date |
---|---|
1.24 | 2024-05-20 |
1.19 | 2024-02-16 |
1.19 | 2023-11-20 |
1.19 | 2023-08-25 |
1.19 | 2023-05-22 |
1.13 | 2023-02-17 |
Split | Date |
---|---|
2 : 1 | 2001-06-13 |
2 : 1 | 1996-06-12 |
2 : 1 | 1992-06-10 |
2 : 1 | 1989-05-11 |
3 : 1 | 1981-05-19 |
3 : 1 | 1970-05-18 |
-
Robinhood is giving away a free share in a company when you sign up. There is no monthly fees or commission fees. The share can range in price from $4.50 - $259. This is especially helpful for those who are now living from paycheck to paycheck and penny pinching. Take care everyone in these times.
-
Let’s buy more JJ
-
-
No Mr. Slayer as we
Have a very long term outlook unlike you. We are cheering the economy of our great country and are wishing that people like you disappear from this world so that American people can continue to keep their jobs. -
-
-
-
-
Yea that’s
-
The market missed it the judge declared 500 million for year one and said he didn’t have enough information going forward to determine monetary damages. Judge will revisit this monies will be much greater. Market will readjust tomorrow morning
-
That 500 million verdict was for year one. The market got it wrong. Judge said he didn’t have enough info for future years. Market will readjust tomorrow morning
-
-
-
-
-
(JNJ) Trading Advice
news.google.com • -
Johnson & Johnson Stock: Buy, Sell, or Hold?
fool.com • -
Johnson & Johnson Stock: Buy, Sell, or Hold?
news.google.com • -
Generational Wealth Builders: 3 Stocks to Own for Decades of Gains
investorplace.com • -
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
news.google.com • -
Are You Looking for a High-Growth Dividend Stock?
news.google.com • -
5 Stocks in Focus on Their Recent Dividend Hike
zacks.com • -
How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?
investorplace.com • -
Johnson & Johnson (NYSE:JNJ) Shares Down 1.1%
news.google.com • -
3 Long-Term Stocks to Buy on the Dip: April 2024
news.google.com • -
Bert's March Dividend Income Summary
seekingalpha.com • -
LLY vs. JNJ: Which Big Pharma Stock Is Better?- TipRanks
news.google.com • -
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
investorplace.com • -
Johnson and Johnson (JNJ) Elliott Wave technical analysis [Video]
news.google.com • -
4 Stocks to Watch on Their Recent Dividend Hikes
zacks.com • -
Johnson & Johnson: Legal Woes Are Detrimental But Not Fatal (NYSE:JNJ)
news.google.com • -
20 Years To $300k? Building A $10,000 Dividend Portfolio From Scratch
seekingalpha.com • -
Investing for the Long-Term: 3 Stocks With Proven Track Records
investorplace.com • -
Recession-Proof Riches: 3 Stocks That Thrive in Any Economy
investorplace.com • -
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
investorplace.com • -
Stocks on the move: UnitedHealth and Johnson & Johnson
youtube.com • -
Building Permits Come in Lower Than Expected
zacks.com • -
J&J's first quarter profits top estimates on strong cancer drug sales
proactiveinvestors.com • -
Johnson & Johnson Stock Slips After Mixed Q1 Earnings Report
investopedia.com • -
Johnson & Johnson is as Cheap as it's Going to Get
marketbeat.com • -
6 Dividend Aristocrats to Buy for Reliable Passive Income
247wallst.com • -
J&J CFO Joseph Wolk on Q1 earnings
youtube.com • -
Here's What To Expect From Johnson & Johnson's Q1
forbes.com • -
3 Blue Chip Stocks For Your April 2024 Watchlist
stockmarket.com • -
The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash
investorplace.com • -
3 Quarterly Releases to Watch Next Week
zacks.com • -
55 April Dividend Kings: Buy 8, Watch 8
seekingalpha.com • -
Johnson & Johnson: Doubling Down On This 2024 Dog Of The Dow
seekingalpha.com • -
Johnson & Johnson expected to face dip in first-quarter earnings
proactiveinvestors.com • -
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
investorplace.com • -
All-Time High Flyers: 7 Stocks to Buy as the Market Peaks
investorplace.com • -
Rallybio partners with J&J to advance therapies targeting rare fetal disease
proactiveinvestors.com • -
Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024
investorplace.com • -
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
investorplace.com • -
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
marketbeat.com • -
Johnson & Johnson to acquire medical device company Shockwave Medical for $13.1B
proactiveinvestors.com • -
Shockwave Medical Stock Rises After Johnson & Johnson Buyout
schaeffersresearch.com • -
SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson
investorplace.com • -
Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion
investors.com • -
Johnson & Johnson to acquire Shockwave Medical in $13.1 billion deal
marketwatch.com • -
Johnson & Johnson to buy Shockwave Medical for $12.5 bln
reuters.com •